The final day of SABCS 20 included the session “View from the Trenches: What Will You Do on Monday Morning,” featuring a multidisciplinary panel of experts who discussed some of the most important data and study findings presented during the meeting.
Large prospective cohort studies have provided valuable insights into breast cancer risk at the population level. But broad characteristics such as age, body mass index, type of cancer, age at diagnosis, and progression are just the beginning.
Tumor infiltrating lymphocytes are an immunologic novelty that is moving toward clinical utility in breast cancer prognosis and treatment selection. In her AACR Award Lecture, Sherene Loi, PhD, FRACP, described ongoing research into the role of TILs in breast cancer prognosis and progression.
With the SABCS 20 Virtual Symposium in the books, the SABCS Executive and Program Planning committees would like to thank everyone who participated in planning and presenting this year’s meeting, and a special thanks to everyone across the globe who attended.